• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Comput Biol . Modelling the impact of vaccination on COVID-19 in African countries

tetano

Editor, Senior Moderator
PLoS Comput Biol


. 2024 Oct 23;20(10):e1012456.
doi: 10.1371/journal.pcbi.1012456. eCollection 2024 Oct. Modelling the impact of vaccination on COVID-19 in African countries

Dephney Mathebula[SUP] 1 [/SUP], Abigail Amankwah[SUP] 2 [/SUP], Kossi Amouzouvi[SUP] 3 4 [/SUP], Kétévi Adiklè Assamagan[SUP] 5 [/SUP], Somiealo Azote[SUP] 6 [/SUP], Jesutofunmi Ayo Fajemisin[SUP] 7 [/SUP], Jean Baptiste Fankam Fankame[SUP] 8 [/SUP], Aluwani Guga[SUP] 9 [/SUP], Moses Kamwela[SUP] 10 [/SUP], Mulape Mutule Kanduza[SUP] 11 [/SUP], Toivo Samuel Mabote[SUP] 12 [/SUP], Francisco Fenias Macucule[SUP] 13 [/SUP], Azwinndini Muronga[SUP] 14 [/SUP], Ann Njeri[SUP] 15 [/SUP], Michael Olusegun Oluwole[SUP] 16 [/SUP], Cláudio Moisés Paulo[SUP] 17 [/SUP]



Affiliations
Abstract

The rapid development of vaccines to combat the spread of COVID-19, caused by the SARS-CoV-2 virus, is a great scientific achievement. Before the development of the COVID-19 vaccines, most studies capitalized on the available data that did not include pharmaceutical measures. Such studies focused on the impact of non-pharmaceutical measures such as social distancing, sanitation, use of face masks, and lockdowns to study the spread of COVID-19. In this study, we used the SIDARTHE-V model, an extension of the SIDARTHE model, which includes vaccination rollouts. We studied the impact of vaccination on the severity of the virus, specifically focusing on death rates, in African countries. The SIRDATHE-V model parameters were extracted by simultaneously fitting the COVID-19 cumulative data of deaths, recoveries, active cases, and full vaccinations reported by the governments of Ghana, Kenya, Mozambique, Nigeria, South Africa, Togo, and Zambia. Using South Africa as a case study, our analysis showed that the cumulative death rates declined drastically with the increased extent of vaccination drives. Whilst the infection rates sometimes increased with the arrival of new coronavirus variants, the death rates did not increase as they did before vaccination.


 
Back
Top Bottom